Breaking News Instant updates and real-time market news.

SQM

SQM

$27.83

-0.02 (-0.07%)

19:56
11/23/16
11/23
19:56
11/23/16
19:56

SQM reports Q3 EPS 21c, consensus 29c

Reports Q3 revenue $504M, one estimate $443.21M. "In general, trends seen during Q3 were in line with what we have seen in previous months: higher prices in lithium, lower prices in iodine, lower average prices in the potassium chloride market, and increased price pressure in the specialty plant nutrient market."

SQM SQM
$27.83

-0.02 (-0.07%)

10/19/16
HSBC
10/19/16
UPGRADE
Target $35
HSBC
Buy
SQM upgraded to Buy from Hold at HSBC
HSBC analyst Alexandre Falcao upgraded SQM to Buy and raised its price target to $35 from $24.50. The analyst expects lithium supply/demand dynamics will remain relatively tight at least until the end of this decade and sees demand remaining robust and growing to 2.5x current levels by 2025, driven by electric vehicles and energy storage applications. Further, the possible entry of Tianqi or another potential bidder into SQM's control block in Chile would be a positive as it could improve corporate governance standards and increase the likelihood of conciliation with CORFO and of a renewal of the brine concession, the analyst wrote.
11/08/16
BMOC
11/08/16
INITIATION
BMOC
Market Perform
SQM initiated with a Market Perform at BMO Capital
Target $30.
11/08/16
11/08/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Adient (ADNT) initiated with a Neutral at JPMorgan. 2. JinkoSolar (JKS) initiated with a Buy at Craig-Hallum. 3. Amgen (AMGN), Gilead (GILD), and Celgene (CELG) initiated with a Buy at Mizuho while the firm initiated Biogen (BIIB) with a Neutral. 4. BioScrip (BIOS) resumed with a Buy at Jefferies. 5. SQM (SQM) initiated with a Market Perform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/15/16
DBAB
11/15/16
INITIATION
Target $33
DBAB
Buy
SQM initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Chris Terry started SQM with a Buy rating and $33 price target. The analyst highlights the company's "growing profitability" in lithium through volume and price.

TODAY'S FREE FLY STORIES

VC

Visteon

$131.85

-0.54 (-0.41%)

09:13
01/22/18
01/22
09:13
01/22/18
09:13
Recommendations
Visteon analyst commentary  »

Visteon price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNX

Mellanox

$65.75

0.65 (1.00%)

09:12
01/22/18
01/22
09:12
01/22/18
09:12
Conference/Events
Mellanox management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

IOVA

Iovance Biotherapeutics

$10.70

1.075 (11.17%)

09:12
01/22/18
01/22
09:12
01/22/18
09:12
Recommendations
Iovance Biotherapeutics analyst commentary  »

Iovance Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

09:11
01/22/18
01/22
09:11
01/22/18
09:11
Hot Stocks
Halliburton says International business started to recover in 2H17 »

Comments from Q4 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

09:10
01/22/18
01/22
09:10
01/22/18
09:10
General news
Treasury Option Action: doubly bullish positioning »

Treasury Option Action:…

GRA

W.R. Grace

$73.71

0.92 (1.26%)

09:09
01/22/18
01/22
09:09
01/22/18
09:09
Hot Stocks
W.R. Grace licenses UNIPOL PP process technology to Poland's Grupa Azoty »

W. R. Grace has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 02

    Mar

PRI

Primerica

$104.50

1.3 (1.26%)

09:09
01/22/18
01/22
09:09
01/22/18
09:09
Recommendations
Primerica analyst commentary  »

Primerica price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

ARCT

Arcturus Therapeutics

$9.15

-0.15 (-1.61%)

09:08
01/22/18
01/22
09:08
01/22/18
09:08
Initiation
Arcturus Therapeutics initiated  »

Arcturus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTH

Meritage Homes

$52.15

0.45 (0.87%)

09:08
01/22/18
01/22
09:08
01/22/18
09:08
Upgrade
Meritage Homes rating change  »

Meritage Homes upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

INSG

Inseego

$1.66

-0.01 (-0.60%)

09:08
01/22/18
01/22
09:08
01/22/18
09:08
Hot Stocks
Inseego says board adopts NOL rights plan »

Inseego Corp. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$179.64

4.16 (2.37%)

09:06
01/22/18
01/22
09:06
01/22/18
09:06
Hot Stocks
Breaking Hot Stocks news story on Wynn Resorts »

Wynn Resorts reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

XRX

Xerox

$31.80

0.43 (1.37%)

09:06
01/22/18
01/22
09:06
01/22/18
09:06
Hot Stocks
Icahn, Deason call on Xerox to explore strategic alternatives, replace CEO »

Carl Icahn and Darwin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$179.64

4.16 (2.37%)

09:05
01/22/18
01/22
09:05
01/22/18
09:05
Hot Stocks
Breaking Hot Stocks news story on Wynn Resorts »

Wynn Resorts reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

WYNN

Wynn Resorts

$179.64

4.16 (2.37%)

09:05
01/22/18
01/22
09:05
01/22/18
09:05
Earnings
Wynn Resorts reports Q4 adjusted EPS $1.40, consensus $1.38 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

FFBC

First Financial Bancorp

09:04
01/22/18
01/22
09:04
01/22/18
09:04
Upgrade
First Financial Bancorp rating change  »

First Financial Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVAX

Dynavax

, GSK

GlaxoSmithKline

$38.20

0.03 (0.08%)

09:04
01/22/18
01/22
09:04
01/22/18
09:04
Recommendations
Dynavax, GlaxoSmithKline analyst commentary  »

Dynavax has sold off 30%…

DVAX

Dynavax

GSK

GlaxoSmithKline

$38.20

0.03 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 26

    Feb

  • 25

    Mar

  • 23

    Apr

EGP

EastGroup Properties

$84.88

1.43 (1.71%)

09:04
01/22/18
01/22
09:04
01/22/18
09:04
Upgrade
EastGroup Properties rating change  »

EastGroup Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

ENZ

Enzo Biochem

$7.96

0.17 (2.18%)

09:04
01/22/18
01/22
09:04
01/22/18
09:04
Hot Stocks
Enzo Biochem announces validation of cervical cancer biomarker detection test »

Enzo Biochem announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRS

Harris

$145.89

0.15 (0.10%)

09:03
01/22/18
01/22
09:03
01/22/18
09:03
Hot Stocks
Harris selected by U.S. Air Force for F-16 EW system support program »

The U.S. Air Force has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 21

    Feb

LGND

Ligand

$155.81

5.25 (3.49%)

09:01
01/22/18
01/22
09:01
01/22/18
09:01
Hot Stocks
Ligand, Ferring Pharmaceuticals enter into OmniAb platform license agreement »

Ligand Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTR

Frontier Communications

$7.77

0.56 (7.77%)

09:01
01/22/18
01/22
09:01
01/22/18
09:01
Hot Stocks
Frontier Communications launches Total360 continuity service nationwide »

Frontier Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

BAESY

BAE Systems

$33.30

0.18 (0.54%)

09:01
01/22/18
01/22
09:01
01/22/18
09:01
Hot Stocks
BAE Systems to provide U.S. Navy with modernized Mk 45 guns in $46.8M contract »

The U.S. Navy has awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WRI

Weingarten Realty

$30.76

0.26 (0.85%)

09:00
01/22/18
01/22
09:00
01/22/18
09:00
Upgrade
Weingarten Realty rating change  »

Weingarten Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

IDRA

Idera Pharmaceuticals

$2.55

0.145 (6.03%)

09:00
01/22/18
01/22
09:00
01/22/18
09:00
Hot Stocks
Breaking Hot Stocks news story on Idera Pharmaceuticals »

Idera Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCRX

BioCryst

$5.59

-0.09 (-1.58%)

09:00
01/22/18
01/22
09:00
01/22/18
09:00
Hot Stocks
Breaking Hot Stocks news story on BioCryst 

BioCryst trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.